During the past decade, Linong Ji conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Linong Ji" are "Diabetes Mellitus, Type 2" (1 trials) and "Diabetes Type 2" (1 trials). Many other conditions were trialed in "Linong Ji" in a lesser frequency.

Most popular intervention types in "Linong Ji" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Janagliflozin 25mg" (1 trials), "Janagliflozin 50mg" (1 trials), "Janagliflozin plus metformin" (1 trials), "Placebo plus metformin" (1 trials) and "Placebo/Janagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Linong Ji" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Linong Ji". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Linong Ji, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Linong Ji, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".